H.R. 5343

119th Congress

Introduced

Ensuring Patient Access to Critical Breakthrough Products Act

Sponsored byRepublican:Rep. Moore, Blake D. [R-UT-1]UT· Introduced 15 September 2025

62

Cosponsors

6

Actions

0

Amendments

2

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 0 of 0
Latest action

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

17 September 2025·10 months ago

Timeline

6 actions

  1. Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

    17 September 2025 · Committee

  2. Committee Consideration and Mark-up Session Held

    17 September 2025 · Committee

  3. Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    15 September 2025 · IntroReferral

  4. Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    15 September 2025 · IntroReferral

  5. Introduced in House

    15 September 2025 · IntroReferral

  6. Introduced in House

    15 September 2025 · IntroReferral

Sponsorship

62 cosponsors

Sponsor

Republican:Rep. Moore, Blake D. [R-UT-1]UT

Cosponsors

  • Democrat2550%
  • Republican2550%

Classification

Policy area

Health

Legislative subjects

Congressional oversightDrug safety, medical device, and laboratory regulationHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesMedicare

Committees

2

  • Energy and Commerce Committee

    House · Standing

    • Referred To15 Sept 2025
  • Ways and Means Committee

    House · Standing

    • Referred To15 Sept 2025
    • Markup By17 Sept 2025
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.